Autor: |
Denecker G; 1] Unit of Molecular and Cellular Oncology, Inflammation Research Center, VIB, 9052 Ghent, Belgium [2] Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium., Vandamme N; 1] Unit of Molecular and Cellular Oncology, Inflammation Research Center, VIB, 9052 Ghent, Belgium [2] Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium., Akay O; 1] Unit of Molecular and Cellular Oncology, Inflammation Research Center, VIB, 9052 Ghent, Belgium [2] Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium., Koludrovic D; Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS, INSERM, Université de Strasbourg, Illkirch, France., Taminau J; 1] Unit of Molecular and Cellular Oncology, Inflammation Research Center, VIB, 9052 Ghent, Belgium [2] Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium., Lemeire K; Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium., Gheldof A; 1] Unit of Molecular and Cellular Oncology, Inflammation Research Center, VIB, 9052 Ghent, Belgium [2] Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium., De Craene B; 1] Unit of Molecular and Cellular Oncology, Inflammation Research Center, VIB, 9052 Ghent, Belgium [2] Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium., Van Gele M; Department of Dermatology, Ghent University Hospital, 9000 Ghent, Belgium., Brochez L; Department of Dermatology, Ghent University Hospital, 9000 Ghent, Belgium., Udupi GM; 1] UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College, Dublin 4, Ireland [2] OncoMark Limited, Nova UCD, Belfield Innovation Park, University College Dublin, Belfield, Dublin 4, Ireland., Rafferty M; OncoMark Limited, Nova UCD, Belfield Innovation Park, University College Dublin, Belfield, Dublin 4, Ireland., Balint B; OncoMark Limited, Nova UCD, Belfield Innovation Park, University College Dublin, Belfield, Dublin 4, Ireland., Gallagher WM; 1] UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College, Dublin 4, Ireland [2] OncoMark Limited, Nova UCD, Belfield Innovation Park, University College Dublin, Belfield, Dublin 4, Ireland., Ghanem G; Institute Jules Bordet, Brussels, Belgium., Huylebroeck D; 1] Laboratory of Molecular Biology (Celgen), Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium [2] Department of Cell Biology, Erasmus MC, 3015 GE Rotterdam, The Netherlands., Haigh J; 1] Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium [2] Vascular Cell Biology Unit, Department for Molecular Biomedical Research, VIB, Ghent, Belgium., van den Oord J; Department of Pathology, University Hospital Leuven, KU Leuven, Leuven, Belgium., Larue L; Curie Institute, Developmental Genetics of Melanocytes, Centre National de la Recherche Scientifique (CNRS) UMR3347, Institut National de la Santé et de la Recherche Médicale (INSERM) U1021, Orsay, France., Davidson I; Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS, INSERM, Université de Strasbourg, Illkirch, France., Marine JC; 1] Center for the Biology of Disease, Laboratory for Molecular Cancer Biology, VIB, Leuven, Belgium [2] Center for Human Genetics, KU Leuven, Leuven, Belgium., Berx G; 1] Unit of Molecular and Cellular Oncology, Inflammation Research Center, VIB, 9052 Ghent, Belgium [2] Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium. |